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Abstract  
Silica-coated lanthanum-strontium manganite particles with La0.76Sr0.24MnO3+δ 
stoichiometric formula, exhibiting Curie temperature at ~ 40 oC, were prepared by 
performing a traditional solid-state method of synthesis of magnetic ceramic particles, 
followed by milling and low-temperature coating procedure in aqueous-alcoholic alkali 
medium. The properties of the obtained material establish it as a potential candidate for 
self-regulated power-absorbing and temperature-controlling materials in hyperthermia 
treatments. Moreover, core-comprising LaSr-manganites with different stoichiometries, 
ranging from La0.5Sr0.5MnO3+δ to LaMnO3+δ, were synthesized, with magnetic and 
structural properties thereof examined. Herein reported findings can potentially be 
employed in the preparation of silica-coated magnetic particles with designable Curie 
temperature, offering wide range of adapting possibilities of the material to practical 
instrumental setups in drug delivery and hyperthermia treatments. 
 
Introduction 
 
 Researches related to the development of novel biomedical technologies 
involving in vivo use of magnetic nanoparticles, present relatively young and 
multidisciplinary attempts to overcome the major chemotherapeutic drawback related to 
its spatial non-specificity and, in general, to apply the knowledge of science for the 
medical improvements of life quality1,2. Since the interrelation of many apparently 
separated fields of scientific inquiry (physics, chemistry, biophysical chemistry, 
molecular biology, medicine, and the sub-branches thereof) becomes an essential 
precondition for comprehensive and successful researches of this kind, an inter- or even 
trans-disciplinarity of research methodologies is here clearly called for.  
Magnetic particles are today commonly used in biomedicine for MRI contrast 
enhancement, hyperthermia treatments, drug delivery and targeting1-3, magnetic 
separation, protein detection and purification4, magnetic-field-assisted radionuclide 
therapy5, magnetorelaxometrical diagnostics and eye surgery5, and the detection of 
intracellular molecular interactions6 with the potential of developing gene and/or cellular 
metabolic therapy7 in the near future. Since the aim of this work has been the preparation 
of silica-coated LaSr-manganite with particle sizes within the order of magnitude of 0.1 
μm, we will briefly explain the desired: a.) chemical composition, b.) particle size, and c.) 
coating material in the presented procedure of synthesis. 
a.) LaSr-manganite particles, produced by herein presented method, with Curie 
point (Tc) existing in human hyperthermal range, offer numerous possibilities for 
application in the fields of biology and medicine. For instance, bloodstreaming injection 
of the magnetic particles with certain drugs (that could even be water-insoluble or 
unstable in physiological conditions) attached to their biocompatible surfaces, with 
providing the release of drugs at a specific site by means of an alternating external 
magnetic field, might be one way. The other way may be to force the distributed drug-
carrying particles to release drugs by essentially the same, heating mechanism, but by 
involving appropriate local and manually performed temperature increases, probably in 
the close areas of unhealthy, infected or malignant tissues. Significant magnetoresistance 
effects of manganites - similarly as large magnetocaloric effects - typically observed in 
the immediate vicinity of the Curie point of the material8-11, and potentially envoking 
eddy currents as part of the heating mechanism, might be employed in the addition to the 
ordinary, Tc-limiting production of controlled heat effects by means of an alternating 
external magnetic field, with the aim of selective warming of the given areas of an 
organism. In general, particles that switch certain inherent properties “on/off” in relation 
to relatively simple parameter of temperature, might open possibilities for many potential 
designs of biomedical apparati and useful applications thereof. Although manganites 
have not been used yet in hyperthermia or any other biomedical treatments, many 
different materials, exhibiting relatively low Tc, including Cu-Ni12,13, Pd-Ni14,15, Fe-Pt16, 
Pd-Co17,18, and Ni-Si19 alloys, Co1-xZnxFe2O420, Y3Fe5-xAlxO1220, Fe66P13C7Cr14 
amorphous flakes21 and others have been used, albeit in the majority of cases as 
stationary, interstitial implants. 
b.) It has been shown that successful in vivo attachment of magnetic particles is - 
in certain cases of larger entities, such as the cells - not limited to nano-sized particles, 
but could be even more significant when micron or sub-micron sized magnetic particles 
are employed1, depending largely on the tissue or the organ concerned22. Whereas it is 
said that extracellular maneuvers are limited to particles of less than 50 nm in size23 (with 
natural, ferritin particles being 9 nm in diameter and diffusing rapidly through 
intercellular space3), micron-sized particles (wherein, even though the smallest capillaries 
in the body are 5 – 6 μm in diameter22, particles as large as 200 μm on average were 
successfully applied21,24) are better suited for withstanding the flow dynamics in the 
circulatory system1. Particles of moderate size range (~ 200 nm)25, such as the ones 
prepared within this work, might therefore be optimally suited for the promotion of in 
vivo drug targeting effects. However, it is important to note that there is no perfect 
material for drug delivery, but only a potentially perfect compatibility between the host 
organism, the targeted situation on one side, and the designed biomaterial on the other26. 
 c.) Yet, in order to use magnetic particles for in vivo biomedical applications, their 
surfaces ought to be coated with a given biocompatible and functionalized layer, for 
several reasons. Coating magnetic particles tends to reduce aggregation and 
agglomeration of the particles and minimize protein adsorption, which would, otherwise, 
prevent them from reaching their target. Silica shell, previously prepared within many 
different systems27-32, is also convenient because:5,23  
i) unlike polymers, it is not prone to microbial attacks, and does 
not swell or change porosity in relation to pH changes;  
ii) being chemically inert, it does not affect the redox reactions at 
the particle surfaces;  
iii) it limits the oxidation of particles surfaces, aging processes and 
degradation of the coated solid compound into oxides and/or 
hydroxides of constitutive cations;  
iv) it offers options to covalently bind amino, carboxyl and other 
functional groups to hydroxyl groups on its surface;33  
v) it confers high stability to suspensions of particles at high 
volume fractions, pH changes or electrolyte concentrations.  
All in all, the existence of a Tc-determined, higher limit of heat production of the 
magnetic material in an alternating magnetic field of certain intensity, that could 
potentially overcome the difficulties arising out of the undesired outspreading of 
extensive heat toward healthy regions of the hyperthermically treated tissues, presents an 
attractive - although has not been used in medicine practice yet - property of silica-coated 
manganite particles with relatively low Tc. Although it has recently been stated that there 
is currently no suitable magnetic material for the preparation of magnetic fluids with an 
ideal Tc for hyperthermia treatments34, such biocompatible materials with optimal Tc 
required in magnetic fluid hyperthermia treatments (44 – 47 oC) as prepared within this 
work, that would allow for the auto-regulated power absorption and temperature control 
in an AC magnetic field, might prove to be of an enormous significance to medical 
treatments of the future.  
 
Experimental 
 
Lanthanum-strontium manganite (La1-xSrxMnO3+δ) powders with different 
stoichiometries (x = 0, 0.16, 0.24, 0.33, 0.5) were prepared by calcinations (at 1200 oC 
for 2h in air) of mixtures of Mn3O4, La2O3 and SrCO3, previously homogenized by 
milling in a YZrO2 planetary ball mill at 300 rpm for 2h. The sample with supposedly 
optimal Tc, characterized by its x = 0.24 Sr content in La1-xSrxMnO3+δ stoichiometric 
formula, was chosen for further processing. The respective sample was milled under the 
same conditions as when homogenization had been performed, with and without the 
addition of NaCl, which was previously proven as an effective dispersing agent35. The 
powder milled for 4h, attaining an average particle size of 100 nm, was subsequently 
coated with silica by inducing hydrolysis and condensation of tetraethylorthosilicate 
(TEOS) in the presence of ammonia and 2-propanol. 80 mg of the milled LaSr-manganite 
powder was, under agitation with a magnetic bar, dispersed in 100 ml of 1.7-M 
concentrated (25%wt) aqueous ammonia solution in 2–propanol. After the addition of 
manganite particles in the primary alkali solution, the tightly closed container was 
thermostated at T = 40 °C for 1 h. When the dispersion reached uniform temperature, 
TEOS in concentration of 4.5 mmol/l was added in the mixture, with aging continued for 
20 h. The resulting solids were separated by performing magnetic decantation, and dried 
at 70 °C. X-ray diffraction (XRD) analysis (D4 Endeavor), magnetic measurements 
(Manics DSM10), specific-surface area measurements (Micromeritics Gemini II) and 
transmission electron microscopy (TEM, JEOL JEM-2000FX), were used for the 
characterization of the prepared, both pure and silica-coated LaSr-manganite powders. 
 
Results and discussion 
 
 XRD patterns of the synthesized La1-xSrxMnO3+δ samples with x = 0, x = 0.16, x = 
0.24, x = 0.33, and x = 0.5 stoichiometries, are presented in Fig. 1. Pure manganite 
samples are obtained, albeit at different lowest calcination temperatures: 1000 oC in cases 
of x = 0 and x = 0.33 stoichiometries, x = 1100 oC in cases of x = 0.16 and x = 0.24 
stoichiometries, and 1200 oC in case of x = 0.5 stoichiometry. The transition from doublet 
to singlet peaks on the corresponding XRD patterns, observed with the increase in 
parameter “x”, is ascribed to the transition of rhombohedral (hexagonal) (R3c (167) space 
group) towards pseudo-cubic (Pm3m space group) crystal structure36,37. 
 
Fig. 1. XRD patterns of the synthesized La1-xSrxMnO3+δ samples with x = 0, x = 0.16, x = 0.24, x = 0.33, 
and x = 0.5 stoichiometries. LaSr-manganite diffraction peaks are denoted with “o”, whereby aluminium 
reflections from the sample holder are denoted with “Δ”. 
 
 
   a.)      b.) 
Fig. 2. Specific surface-area (a, ------), average particle size calculated therefrom (a, ––––), and specific 
saturation magnetization (b) vs. milling time dependencies for x = 0.24 LaSr-manganite sample, with (-o-) 
and without (-Δ-) the addition of NaCl as a dispersing agent. 
 
 Increasing specific-surface area and the respective decrease in average particle 
size, together with the decreasing rate of change in specific-surface area and the average 
particle size with milling time, are evident from Fig. 2a. Whereas after 1h of milling, 
average particle size - as calculated from specific-surface area measurements with an 
approximation of spherical particle shapes and theoretical density of the prepared 
compound – decreases to ~ 30 % of its initial value, that is from ~ 500 nm to ~ 150 nm, 
between 1 and 4 h of milling time, average particle size decreases by only ~ 30 %, that is 
from ~ 150 nm to ~ 100 nm. The dependence of specific saturation magnetization versus 
milling time follows a similar trend of decreasing rate of decrease in magnetization in 
relation to milling time - albeit only in the case when milling was performed in the 
absence of NaCl - as can be seen from Fig. 2b. NaCl is in this case, contrary to its 
intended function, proven to be effective in retaining initial magnetization values 
throughout the milling treatment (Fig. 2b), as well as in reducing the number of 
mechanical contacts that lead to the particles fractures, as can be seen by comparing the 
the full-lined plots in Fig. 2a. 
 
Fig. 3. XRD patterns of LaSr-manganite sample with x = 0.24 stoichiometry (a), of the same sample milled 
for 4h (b), and of the latter sample coated with silica (c). LaSr-manganite diffraction peaks are denoted with 
“o”, whereby aluminium reflections from the sample holder are denoted with “Δ”. 
 
X-ray diffractograms of: (a) as-obtained LaSr-manganite sample with x = 0.24 
stoichiometry, (b) milled sample of the same stoichiometry and (c) both milled and silica-
coated sample of the same stoichiometry, are shown in Fig. 3, wherefrom it is obvious 
that the initial manganite compound preserves its perovskite crystal structure after milling 
and coating treatments. The percentage of silica within the coated sample was below the 
detection limit of the performed XRD analysis, as can be concluded from non-appearance 
of silica-derived diffraction peaks in Fig. 3c.   
 
 
   a.)      b.) 
Fig. 4. Specific magnetization at H = 0.1 T (a) and the respective derivatives (b) vs. measuring temperature 
dependencies for x = 0.16 (□), 0.24 (o), 0.33 (∆) and 0.5 () samples, all calcined at 1200 oC.  
 
 
             (a)       (b) 
Fig. 5. Specific magnetization at the external field of 0.5 T vs. measuring temperature (a) and dM/dT vs. 
measuring temperature dependencies (b) of x = 0.24 LaSr-manganite sample (●), and of the same sample, 
subsequently milled for 4h and coated with silica (o). Dashed line signifies the difference between the 
milled, silica-coated and non-coated samples. 
 
 
   a.)      b.) 
Fig. 6. Hysteresis loops, saturation (-o-) and remanence (-■-) magnetizations of the prepared x = 0.24 LaSr-
manganite sample (a), and of the same sample, subsequently milled for 4h (b) and then coated with silica 
(c). 
 
Specific magnetizations and the respective derivatives vs. measuring temperature 
dependencies for all the synthesized samples, are presented in Figs. 4 and 5. Hysteresis 
loops of the synthesized x = 0.24 LaSr-manganite sample, and of the same sample 
subsequently milled and coated, are presented in Fig. 6a, whereas the corresponding 
decrease in both magnetization of saturation and remanence with milling and coating 
treatments, is presented in Fig. 6b. With an increase of parameter “x”, that is of strontium 
content in LaSr-manganite stoichiometric formula, Tc determined as dM2/dT2 = 0 point in 
the corresponding M = f(T) diagram, increases as well (Fig. 4), which is consistent with 
similar findings from literature38. Thus, x = 0.16 sample has Tc = 25 oC, x = 0.24 sample 
has Tc = 60 oC, x = 0.33 sample has Tc = 90 oC, x = 0.5 sample has Tc = 100 oC, whereby 
x = 0 sample exhibits Tc below room temperature.  
Acknowledging the observed facts that Tc decreased when silica or polymer 
coatings were introduced in the system12,39, x = 0.24 sample was chosen for further 
processing with an aim to obtain Tc in a typical temperature range used in hyperthermia 
treatments (42 – 47 oC). This presumption has been indeed observed in reality, and can be 
evidenced by comparing dM/dT versus T dependencies of pure, non-milled and milled, 
silica-coated x = 0.24 LaSr-manganite samples in Fig. 5b. Whereas the former sample has 
Tc ~ 60 oC, the silica-coated sample, albeit with less narrow Curie transition, has Tc ~ 40 
oC. However, a negligible difference in Tc between silica-coated and non-coated milled x 
= 0.24 LaSr-manganite powder (Fig. 6), bears the fact that despite previously evidenced 
structural modifications of the surrounding-dependent particle surfaces with the addition 
of silica coatings40 – with the knowledge of the fact that any chemical modification of the 
surface alters the magnetic properties of the system – that might potentially influence the 
Curie point of a sample, the reduction in interparticle and interdomain interactions caused 
by the milling treatment is in our case seen as the major reason for the observed reduction 
in Tc between the as-prepared x = 0.24 LaSr-manganite powder and the same, afterwards 
milled and coated sample. The most significant influential part in the decrease in 
saturation magnetization during the coating treatment, obvious from Fig. 6a, belongs to 
the effect of decreasing average particle size with milling treatment, as was evidenced 
from Fig. 2, whereby only a small part of ~ 20 % belongs to the weight contribution of 
silica coating. That it is weight contribution being most decisive here, is obvious from the 
close correlation between the decrease slopes of saturation and remanence magnetizations 
with treatment steps, whereby coercivity remains unchanged thoroughout the milling and 
coating procedures, at ~ 40 G. 
The relatively low slope of M = f(T) curve in the range of the Curie transition, 
might have already stood as an indication of negligible decrease in the limiting 
temperature of material with the addition of silica component, since it is known that the 
sharpness of the Curie transition, being the measure of the quality of temperature control, 
is limited by the asymptote of the power absorption41. It can be calculated from Fourier’s 
law that even in case of an infinite thickness of the coated silica layer, the expected 
decrease in the resulting Tc would be, due to relatively small, nano-sized cores of the 
particles and thus small magnitude of energy absorption per particle, in the range of mK. 
However, as has already been said, the decreases in Curie temperature by ~ 30 K were 
noticed when the original magnetic particles were encapsulated either with silica39 or 
polyethylene glycol12.  
If Tc would have been determined by the point of intersection of extrapolated 
tangents of M = f(T) curve below and above the critical transition, higher obtained value 
would not restrict the material from the intended usage. In this context, it is worth noting 
that ferromagnetic implants (Fe-Pt alloy) with Tc ~ 70 oC were successfully used for 
preoperative interstitial hyperthermia42, as well as that a finite element heat-transfer 
model (although relatively poor level of experimental correlations with theoretical 
heating predictions is generally acknowledged in this field18) of ferromagnetic 
thermoseeds and catheters developed for simulating hyperthermia, suggested Curie point 
of ~ 63 oC as an optimal value over nearly all the analyzed blood perfusion cases43. In 
fact, it is known that due to unsteady vascular and neural structures within malignant 
tissues, tumors are much more easily heated than healthy tissues, receding at ~ 43 oC, 
whereas healthy cells - due to better oxygen supply and more developed and flexible both 
inner, molecular metabolic networks and higher-level organization of multi-cellular 
networks that incorporate them - can survive much higher temperatures without 
significant damage44. Magnetic thermoblation that uses temperatures of up to 55 oC is 
therefore sometimes preferred over magnetic hyperthermia that normally involves 
temperatures of up to 44 oC.3 
 
          
 
Fig. 7. TEM images of the milled (a) and subsequently coated with silica (b – g), LaSr-manganite sample 
with x = 0.24 stoichiometry. 
 
 From the TEM image of the milled x = 0.24 LaSr-manganite powder, presented in 
Fig. 7a, finely dispersed particles with relatively wide distribution of sizes, ranging from 
few tens to few hundreds of nanometers, together with irregular shapes thereof, typical 
for milling treatments in general, can be discerned. TEM images of silica-coated LaSr-
manganite particles are presented in Figs. 7b-g, with darker areas within the particle 
images indicating the presence of manganite phase and lighter spherical contours 
belonging to silica coatings. Manganite cores of the particles in the size range of 20 – 100 
nm, consistent with the results obtained from specific-surface area measurements, are 
visible on the corresponding images, whereby spherical silica coatings possess radii of ~ 
120 nm, with narrow, almost monodisperse distribution of sizes thereof. Single and few 
overlapping silica-encapsulated LaSr-manganite particles are presented in Figs. 7c,d and 
Fig. 7b, respectively, whereas a typical agglomerate of precursor, milled manganite 
particles, surrounded with uniformly thick silica layer, is shown in Fig. 7e. Most of the 
manganite particles are observed as coated with silica, which is a favourable precondition 
for eliminating antigenical effects related to the potential recognition of manganite 
surfaces - but not of silica surfaces as well - by macrophages of mononuclear phagocyte 
system, once the particles are injected in the bloodstream. Furthermore, since thoroughly 
coated with silica, the manganite particles could be conjunctioned with biomolecules 
(enzymes, antibodies, DNA, etc.) and sugars (dextrans, starch, albumin, poly(ethylene 
glycol), etc.) for the production of more complex magnetically-guided site-specific drug 
delivery systems45. However, a relatively large percentage of hollow silica spheres can be 
discerned from Fig. 7f,g. The reason for the presence of different morphological patterns 
within the finally synthesized samples can be found in the roots of traditional, solid-state 
approach to materials synthesis, coupled with milling treatments, that in general leaves 
final products with wide distribution of most properties per particle, subsequently in our 
case reflecting on a similar non-uniformity of particle shapes and a variety of the 
obtained nano-structures. However, high temperatures of calcination, as well as complex 
pathways of the formation of mixed rare-earth manganites, significantly decrease or even 
fundamentally limit the space of possible reaction conditions that lead to certain 
uniformities, regarding both morphologies and magnetic characteristics. Wet methods of 
synthesis, although they may not overcome such limits, could drastically widen such 
probability spaces, as has already been in many occassions proven in practice, wherein 
many novel sets of limiting conditions within specific procedures of synthesis, are daily 
discovered in laboratories world-wide. Future researches concerning the preparation of 
biocompatibly coated LaSr-manganites might be directed in such a way.  
 
Conclusions 
 
 A successful pathway for the preparation of silica-coated lanthanum-strontium 
manganite particles with La0.76Sr0.24MnO3+δ stoichiometric formula, exhibiting resulting 
Curie temperature at ~ 40 oC, was presented. Calcination in air at 1200 oC for 2 h, 
followed by 4h milling treatment, and the subsequent wet procedure for encapsulating the 
produced particles with silica, comprised the basic synthesis steps towards the final 
material. The produced pure manganite particles were sized in the range of 10 – 200 nm, 
whereas the final, silica-coated manganite spheres had almost uniformly ~ 250 nm in 
diameter. Larger agglomerates of the milled precursor manganite particles were mostly 
coated with amorphous silica layers, enabling complete potential elimination of 
antigenical effects upon in vivo functional implementation of the prepared material. 
Investigated dependencies of Curie temperature on stoichiometry of LaSr-manganite 
particles that comprise cores of the eventual core-shell structures, enables potential 
preparation of silica-coated and therefore biocompatible LaSr-manganite particles with 
tunable Curie point within the broad range of temperatures used in hyperthermia 
treatments: 40 – 70 oC. In general, the presented investigation contributes to the large 
body of knowledge, related to the contemporary attempts of using nanoscience and 
nanotechnologies for improvements of human life.  
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